Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: Tau Mutations
Human wt Tau

Posted 6 March 2005

General Information

Transgene: cDNA construct containing the longest human brain tau isoform (T40) (hWT tau) was cloned into the mouse prion promoter (MoPrP.Xho) expression vector at the XhoI site. A 15.3 kb NotI fragment containing T40, the MoPrP promoter, together with its 3' and 5' untranslated sequences, was microinjected into fertilized C57BL6 x C3H (B6C3/F1) mouse eggs and then implanted into pseudopregnant females. Two lines of hWT tau Tg mice (lines 1 and 23) that stably expressed the T40 human tau isoform were identified. Most experiments performed on line 23.

Mutation: human WT tau mutation

Promoter: Mouse prion protein promoter (MoPrP)

Mouse Strain: B6C3

Phenotype

Neuropathological Analysis:

Human Tau expression is 8-10 times higher than endogenous tau in line 23. No age-dependent accumulation of tau aggregates, no neurodegeneration.

Behavioral:

90% survive to 24 months

Availability

Contact: Virginia M-Y Lee
The Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine
Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Phone: 215-662-6427
Fax: 215-349-5909
Email: vmylee@mail.med.upenn.edu

Patents:

References

Primary:

Zhang B, Higuchi M, Yoshiyama Y, Ishihara T, Forman M S, Martinez D, Joyce S, Trojanowski J Q, Lee V M-Y. Retarded Axonal Transport of R406W Mutant Tau in Transgenic Mice with a Neurodegenerative Tauopathy. J Neurosci. 24(19):4657-4667, 2004. Abstract.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad